These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28640595)
21. Effect of Ionic Strength on Thioflavin-T Affinity to Amyloid Fibrils and Its Fluorescence Intensity. Mikalauskaite K; Ziaunys M; Sneideris T; Smirnovas V Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255444 [TBL] [Abstract][Full Text] [Related]
22. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer. Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458 [TBL] [Abstract][Full Text] [Related]
23. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646 [TBL] [Abstract][Full Text] [Related]
24. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
25. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation. Fonseca-Ornelas L; Eisbach SE; Paulat M; Giller K; Fernández CO; Outeiro TF; Becker S; Zweckstetter M Nat Commun; 2014 Dec; 5():5857. PubMed ID: 25524885 [TBL] [Abstract][Full Text] [Related]
26. Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor. Afitska K; Priss A; Yushchenko DA; Shvadchak VV J Mol Biol; 2020 Feb; 432(4):967-977. PubMed ID: 31809698 [TBL] [Abstract][Full Text] [Related]
27. Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations. Dasari AKR; Kayed R; Wi S; Lim KH Biochemistry; 2019 Jun; 58(25):2814-2821. PubMed ID: 31132261 [TBL] [Abstract][Full Text] [Related]
28. Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids. Horrocks MH; Lee SF; Gandhi S; Magdalinou NK; Chen SW; Devine MJ; Tosatto L; Kjaergaard M; Beckwith JS; Zetterberg H; Iljina M; Cremades N; Dobson CM; Wood NW; Klenerman D ACS Chem Neurosci; 2016 Mar; 7(3):399-406. PubMed ID: 26800462 [TBL] [Abstract][Full Text] [Related]
29. Following the fate of endocytosed fibrils. Hasegawa M; Suzuki G J Biol Chem; 2017 Aug; 292(32):13498-13499. PubMed ID: 28801354 [TBL] [Abstract][Full Text] [Related]
30. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases. Longhena F; Spano P; Bellucci A Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171 [TBL] [Abstract][Full Text] [Related]
32. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein. Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292 [TBL] [Abstract][Full Text] [Related]
33. Polymorph-specific distribution of binding sites determines thioflavin-T fluorescence intensity in α-synuclein fibrils. Sidhu A; Vaneyck J; Blum C; Segers-Nolten I; Subramaniam V Amyloid; 2018 Sep; 25(3):189-196. PubMed ID: 30486688 [TBL] [Abstract][Full Text] [Related]
34. Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates. Kundel F; Tosatto L; Whiten DR; Wirthensohn DC; Horrocks MH; Klenerman D FEBS J; 2018 Oct; 285(19):3604-3630. PubMed ID: 29453901 [TBL] [Abstract][Full Text] [Related]
35. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies. Pickhardt M; Neumann T; Schwizer D; Callaway K; Vendruscolo M; Schenk D; St George-Hyslop P; Mandelkow EM; Dobson CM; McConlogue L; Mandelkow E; Tóth G Curr Alzheimer Res; 2015; 12(9):814-28. PubMed ID: 26510979 [TBL] [Abstract][Full Text] [Related]
36. Ligand polarizability contributes to tau fibril binding affinity. Jensen JR; Cisek K; Honson NS; Kuret J Bioorg Med Chem; 2011 Sep; 19(17):5147-54. PubMed ID: 21803586 [TBL] [Abstract][Full Text] [Related]
38. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization. Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987 [TBL] [Abstract][Full Text] [Related]
39. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces. Brown JW; Buell AK; Michaels TC; Meisl G; Carozza J; Flagmeier P; Vendruscolo M; Knowles TP; Dobson CM; Galvagnion C Sci Rep; 2016 Nov; 6():36010. PubMed ID: 27808107 [TBL] [Abstract][Full Text] [Related]
40. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy. Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]